Leviathan Cannabis Group Inc Share Price Toronto S.E.
Equities
CA61762Y1051
Pharmaceuticals
Sales 2022 | 8L 6L 5.15Cr | Sales 2023 | 3.53Cr 2.58Cr 215.88Cr | Capitalization | 22Cr 16Cr 1.33TCr |
---|---|---|---|---|---|
Net income 2022 | -40L -29.24L -24Cr | Net income 2023 | - 0 0 | EV / Sales 2022 | 150 x |
Net Debt 2022 | 88.98L 65.03L 54Cr | Net Debt 2023 | 33.15L 24.23L 20Cr | EV / Sales 2023 | 6.28 x |
P/E ratio 2022 |
-23.4
x | P/E ratio 2023 |
-238
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 87.12% |
Managers | Title | Age | Since |
---|---|---|---|
Tanvi Bhandari
CEO | Chief Executive Officer | - | 07/22/07 |
Director of Finance/CFO | - | 07/22/07 | |
Kamyar Hosseini
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Tanvi Bhandari
CEO | Chief Executive Officer | - | 07/22/07 |
Rupalee Mehta
BRD | Director/Board Member | - | 07/22/07 |
Lucas Leone
BRD | Director/Board Member | - | 07/22/07 |
1st Jan change | Capi. | |
---|---|---|
+61.53% | 86TCr | |
+38.95% | 63TCr | |
-3.66% | 36TCr | |
+15.06% | 32TCr | |
+9.18% | 30TCr | |
+5.89% | 23TCr | |
+16.53% | 23TCr | |
+15.67% | 18TCr | |
+2.47% | 16TCr |